QT
PLRX icon

Quantbot Technologies’s Pliant Therapeutics PLRX Stock Holding History

Quantbot Technologies’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,261
Closed -$164K – 1759
2024
Q2 		$164K Buy
15,261
+14,984
+5,409% +$193K 0.01% 1019
2024
Q1 		$4.13K Buy
+277
New +$4.57K ﹤0.01% 1486
2023
Q4 		– Sell
-32,735
Closed -$568K – 1898
2023
Q3 		$568K Buy
32,735
+6,802
+26% +$118K 0.04% 586
2023
Q2 		$470K Buy
+25,933
New +$614K 0.03% 692
2022
Q3 		– Sell
-2,017
Closed -$16K – 1977
2022
Q2 		$16K Sell
2,017
-183
-8% -$1.17K ﹤0.01% 1477
2022
Q1 		$15K Buy
+2,200
New +$22.5K ﹤0.01% 1413

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Quantbot Technologies's PLRX Position: Q3 2024 in Review

Quantbot Technologies sold out of Pliant Therapeutics (PLRX) in Q3 2024, closing a stake of 15,261 shares — an estimated $164K sold.

Quantbot Technologies first reported a position in PLRX in Q1 2022 and held it in 6 quarters. The position peaked at $568K in Q3 2023. 151 funds tracked by Wall St. Rank hold PLRX as of Q3 2024.

  • Quantbot Technologies reported no remaining Pliant Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Quantbot Technologies sold 15,261 Pliant Therapeutics shares in Q3 2024, an estimated $164K.
  • Quantbot Technologies first reported a position in Pliant Therapeutics in Q1 2022 and held it in 6 quarters.
  • Quantbot Technologies's Pliant Therapeutics position peaked at $568K in Q3 2023.
  • 151 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2024.

Based on Quantbot Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.